Search
Patexia Research
Case number PGR2016-00010

Mylan Pharmaceuticals Inc. v. Yeda Research and Development Co. Ltd. > Documents

Date Field Doc. No.PartyDescription
Oct 18, 2016 11 Notice of Refund Download
Oct 14, 2016 10 Refund Request Download
Aug 15, 2016 9 Trial Instituted Document Download
May 24, 2016 2011 patent_owner A phase 3 trial to assess the efficacy and safety of glatiramer acetate injections 40 mg administered 3 times a week compared to placebo, Abstract 166, Multiple Sclerosis Journal 2012 18(54) 509-520 Download
May 24, 2016 2003 patent_owner Claim Chart Download
May 24, 2016 2005 patent_owner Defendants Initial Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 Download
May 24, 2016 2012 patent_owner U.S. Application No. 14/630,326 Download
May 24, 2016 2009 patent_owner Business Wire, Teva Announces Top-Line Results from GALA Phase III Trial Evaluating a New Dosage for Glatiramer Acetate Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis, June 14, 2012 Download
May 24, 2016 2010 patent_owner Reuters Press Release, New Data Presented at the 28th ECTRIMS Congress Showcase Tevas Ongoing Commitment to Multiple Sclerosis Research, October 8, 2012 Download
May 24, 2016 2000 patent_owner Patent Owner's Exhibit List Download
May 24, 2016 8 patent_owner Patent Owner's Exhibit List Download
May 24, 2016 2014 patent_owner World Health Organization, A Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines, 2009, 129-133 Download
May 24, 2016 2007 patent_owner U.S. Application No. 61/337,612 Download
May 24, 2016 2004 patent_owner U.S. Application No. 13/770,677 Download
May 24, 2016 2001 patent_owner Declaration of Dr. Edward J. Fox Download
May 24, 2016 2002 patent_owner U.S. Application No. 61/274,687 Download
May 24, 2016 2008 patent_owner Khan et al., Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis, Ann. Neurol., 2013 73 705713 Download
May 24, 2016 2013 patent_owner Cobert, et al., Practical Drug Safety from A to Z, Jones and Bartlett Publishers, 2009, pp. 327-329 Download
May 24, 2016 2006 patent_owner U.S. Application No. 12/806,684 Download
May 24, 2016 7 patent_owner Patent Owner Yeda Research and Development Co. Ltd.'s Preliminary Response Download
May 18, 2016 6 patent_owner Power of Attorney Download
Mar 8, 2016 5 potential_po Related Matters Download
Mar 8, 2016 4 potential_po Power of Attorney Download
Feb 24, 2016 3 board Notice of Filing Date Accorded to Petition Download
Feb 16, 2016 1016 petitioner Deposition of Tjalf Ziemssen Download
Feb 16, 2016 1001 petitioner U.S. Patent No. 9,155,776 Download
Feb 16, 2016 1025 petitioner Yeda Patent Owner Response in IPR2015-00644 Download
Feb 16, 2016 1027 petitioner Miller 2004 Download
Feb 16, 2016 1040 petitioner Bakshi 2005 Download
Feb 16, 2016 1034 petitioner Haines 1998 Download
Feb 16, 2016 1039 petitioner Rich 2004 Download
Feb 16, 2016 1047 petitioner Extavia Label Download
Feb 16, 2016 1006 petitioner Plaintiffs' Supplemental Opening Claim Construction Brief Download
Feb 16, 2016 1032 petitioner Common Terminology Criteria for Adverse Events Download
Feb 16, 2016 1015 petitioner Yeda Preliminary Response in IPR2015-00643 Download
Feb 16, 2016 1037 petitioner Soares 2006 Download
Feb 16, 2016 1 petitioner Power of Attorney Download
Feb 16, 2016 1031 petitioner Singer 2012 Download
Feb 16, 2016 1007 petitioner U.S. Patent No. 3,849,550 Download
Feb 16, 2016 1045 petitioner Rebif Label Download
Feb 16, 2016 1043 petitioner Johnson 1995 Download
Feb 16, 2016 1046 petitioner Avonex Label Download
Feb 16, 2016 1008 petitioner File History for U.S. Patent No. 8,969,302, Part 2 Download
Feb 16, 2016 1028 petitioner Stewart 2012 Download
Feb 16, 2016 1010 petitioner 2015 Citizen Petition Download
Feb 16, 2016 1042 petitioner Edgar Download
Feb 16, 2016 1044 petitioner Betaseron Label Download
Feb 16, 2016 1005 petitioner GLACIER Study Details Download
Feb 16, 2016 1022 petitioner U.S. Patent No. 8,399,413 Download
Feb 16, 2016 1035 petitioner Comi 2001 Download
Feb 16, 2016 1036 petitioner Ge 2000 Download
Feb 16, 2016 1024 petitioner Yeda Patent Owner Reponse in IPR2015-00643 Download
Feb 16, 2016 1004 petitioner GALA Study Details Download
Feb 16, 2016 2 petitioner Petition for Post-Grant Review of U.S. Patent No. 9,155,776 Download
Feb 16, 2016 1041 petitioner Stuart 2004 Download
Feb 16, 2016 1020 petitioner Deposition of Edward Fox Download
Feb 16, 2016 1019 petitioner Wolinksy 2014 Download
Feb 16, 2016 1048 petitioner Tysabri Label Download
Feb 16, 2016 1003 petitioner Expert Declaration of Dr. Ari Green Download
Feb 16, 2016 1018 petitioner Teva Press Release Download
Feb 16, 2016 1017 petitioner Comi 2011 Download
Feb 16, 2016 1012 petitioner Copaxone Prescribing Information Download
Feb 16, 2016 1021 petitioner Stipulation Download
Feb 16, 2016 1009 petitioner 2014 Citizen Petition Download
Feb 16, 2016 1014 petitioner Plaintiff Claim Construction Brief Download
Feb 16, 2016 1033 petitioner Frohman 2006 Download
Feb 16, 2016 1030 petitioner McEwan 2010 Download
Feb 16, 2016 1013 petitioner Claim Construction Brief Download
Feb 16, 2016 1011 petitioner McKeage Download
Feb 16, 2016 1029 petitioner Pelidou 2008 Download
Feb 16, 2016 1026 petitioner Yeda Patent Owner Response in IPR2015-00830 Download
Feb 16, 2016 1038 petitioner Wolinsky 2015 Download
Feb 16, 2016 1008 petitioner File History for U.S. Patent No. 8,969,302, Part 2 Download
Feb 16, 2016 1002 petitioner File History for U.S. Patent No. 9,155,776 Download
Feb 16, 2016 1023 petitioner Plaintiff Opening Claim Construction Brief Download
Feb 16, 2016 1008 petitioner File History for U.S. Patent No. 8,969,302, Part 1 Download
Menu